Jean-Claude do Rego Selected Research

Jean-Claude do Rego Research Topics

Disease

6	Body Weight (Weight, Body) 01/2021 - 09/2012
4	Anorexia 01/2021 - 06/2015
3	Obesity 01/2020 - 12/2019
2	Heart Failure 01/2021 - 05/2014
2	Anorexia Nervosa 01/2021 - 06/2015
2	Dysbiosis 01/2021 - 01/2021
2	Catalepsy 10/2019 - 01/2013
2	Depressive Disorder (Melancholia) 09/2012 - 04/2007
1	Weight Gain 01/2021
1	Left Ventricular Dysfunction 01/2021
1	Overweight 01/2020
1	Hyperglycemia 01/2020
1	Schizophrenia (Dementia Praecox) 10/2019
1	Neurobehavioral Manifestations 10/2019
1	Colitis 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Neoplasms (Cancer) 01/2016
1	Weight Loss (Weight Reduction) 01/2016
1	Cachexia 01/2016
1	Mucositis 01/2016
1	Starvation 06/2015
1	Feeding and Eating Disorders (Eating Disorder) 03/2015
1	Sepsis (Septicemia) 05/2014
1	Inflammation (Inflammations) 05/2014
1	Hyperphagia (Overeating) 01/2013
1	Gliosis 01/2013
1	Pain (Aches) 02/2010
1	Hypothermia 12/2005

Drug/Important Bio-Agent (IBA)

4	GhrelinIBA 01/2016 - 01/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2019
3	Immunoglobulin G (IgG)IBA 01/2016 - 01/2013
2	Appetite Depressants (Anorectics)IBA 01/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2021 - 06/2015
2	Insulin (Novolin)FDA Link 01/2021 - 01/2020
2	Biological ProductsIBA 01/2021 - 03/2015
2	Neuropeptide YIBA 01/2021 - 09/2012
2	Neuroprotective AgentsIBA 10/2019 - 01/2018
2	Apomorphine FDA Link 10/2019 - 12/2005
2	Immunoglobulins (Immunoglobulin)IBA 01/2016 - 09/2012
1	Mineralocorticoid Receptor AntagonistsIBA 01/2021
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2021
1	Biological FactorsIBA 01/2021
1	finerenoneIBA 01/2021
1	NeuropeptidesIBA 01/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Melanocyte-Stimulating Hormones (MSH)IBA 01/2020
1	Orlistat (Xenical)FDA Link 12/2019
1	Ketamine FDA LinkGeneric 10/2019
1	ImidazolidinesIBA 10/2019
1	Glutamic Acid (Glutamate)FDA Link 10/2019
1	3- (2- chloro- 6- fluorobenzyl)- imidazolidine- 2,4- dioneIBA 10/2019
1	Antipsychotic Agents (Antipsychotics)IBA 10/2019
1	Sulfonic AcidsIBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2018
1	Methotrexate (Mexate)FDA LinkGeneric 01/2016
1	Hormones (Hormone)IBA 01/2016
1	Peptides (Polypeptides)IBA 06/2015
1	Therapeutic UsesIBA 05/2014
1	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 05/2014
1	LipopolysaccharidesIBA 05/2014
1	barbituric acid (barbiturate)IBA 01/2013
1	AutoantibodiesIBA 09/2012
1	Analgesics (Analgesic Drugs)IBA 02/2010
1	Antidepressive Agents (Antidepressants)IBA 04/2007
1	mu Opioid Receptors (mu Opioid Receptor)IBA 04/2007

Therapy/Procedure

1	Ovariectomy (Oophorectomy) 01/2021
1	Drug Therapy (Chemotherapy) 01/2016
1	Punctures 05/2014
1	Ligation 05/2014
1	Transplantation 01/2013
1	Therapeutics 02/2010